Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DAUNORUBICIN for Kaposi's sarcoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where DAUNORUBICIN was used for Kaposi's sarcoma.

Most Reported Side Effects for DAUNORUBICIN

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 1,311 13.3% 168 683
Pyrexia 645 6.6% 117 419
Neutropenia 631 6.4% 95 300
Sepsis 515 5.2% 207 298
Off label use 462 4.7% 132 149
Pneumonia 402 4.1% 213 176
Bacterial infection 400 4.1% 272 102
Drug ineffective 375 3.8% 137 133
Septic shock 363 3.7% 174 225
Thrombocytopenia 347 3.5% 85 152
Pancytopenia 345 3.5% 89 135
Clostridium difficile colitis 331 3.4% 218 116
Myelosuppression 319 3.2% 25 106
Hypotension 298 3.0% 97 260
Product use in unapproved indication 280 2.8% 80 116

Other Indications for DAUNORUBICIN

Acute lymphocytic leukaemia (3,111) Acute myeloid leukaemia (2,423) Product used for unknown indication (449) T-cell type acute leukaemia (367) B precursor type acute leukaemia (274) Chemotherapy (219) B-cell type acute leukaemia (212) Precursor t-lymphoblastic lymphoma/leukaemia (211) Non-hodgkin's lymphoma (141) Acute promyelocytic leukaemia (137)

Other Drugs Used for Kaposi's sarcoma

POMALIDOMIDE (268) DOXORUBICIN (238) PACLITAXEL (122) VINCRISTINE (78) BLEOMYCIN (58) LENALIDOMIDE (54) ETOPOSIDE (38) RITUXIMAB (27) PREDNISONE (23) GEMCITABINE (21)

Related Pages

DAUNORUBICIN Full Profile All Kaposi's sarcoma Drugs DAUNORUBICIN Demographics DAUNORUBICIN Timeline